SEC Form 4
Progyny, Inc. (PGNY) insider trading
In the 12 months to Oct 26, 2026, 6 PGNY insiders reported open-market sales of $2.3M across 20 filings; one CHIEF EXECUTIVE OFFICER bought $1.9M.
Latest filing · Last 12 months · Source: SEC EDGAR · How we count
- Open-market sales
- $2.3M
- 20 filings · 6 insiders
- Open-market purchases
- $1.9M
- 1 filing · Peter Anevski, CHIEF EXECUTIVE OFFICER
- Pre-arranged sales (10b5-1)
- 16 of 20
- $1.6M of $2.3M sold (70%)
Who traded PGNY, and when
- Purchase
- Sale
- Sale, pre-arranged (10b5-1)
PGNY daily close from Oct 27, 2025 to Oct 26, 2026, between $16.30 and $32.36, last $28.31. 20 sale and 1 purchase filings by 7 insiders, marked at their filing dates. Peter Anevski, CHIEF EXECUTIVE OFFICER: bought $1.9M across 1 filing, first filed Nov 17, 2025, last Nov 17, 2025. Mark S. Livingston, CHIEF FINANCIAL OFFICER: sold $842.9K across 6 filings, first filed Nov 19, 2025, last Jun 5, 2026. Kevin K. Gordon, Director: sold $449.3K across 2 filings, first filed May 29, 2026, last Sep 18, 2026. Allison Swartz, EVP, GC: sold $414.9K across 7 filings, first filed Dec 2, 2025, last Sep 28, 2026. Melissa B. Cummings, Chief Operating Officer: sold $363.0K across 3 filings, first filed May 21, 2026, last Oct 16, 2026. Cheryl Scott, Director: sold $196.3K across 1 filing, first filed Jun 3, 2026, last Jun 3, 2026. Geoffrey Clapp, Chief Product Officer: sold $39.1K across 1 filing, first filed Jun 3, 2026, last Jun 3, 2026.
Largest mark · tap a row for others
Peter Anevski · CHIEF EXECUTIVE OFFICER
Purchase $1,930,896
79,500 shares at $24.29 avg
Filed Nov 17, 2025 · traded Nov 13
Close on filing date $26.82
Peter Anevski · CHIEF EXECUTIVE OFFICER
CHIEF EXECUTIVE OFFICER
$1.9M boughtMark S. Livingston · CHIEF FINANCIAL OFFICER
CHIEF FINANCIAL OFFICER
$842.9K soldKevin K. Gordon · Director
Director
$449.3K soldAllison Swartz · EVP, GC
EVP, GC
$414.9K soldMelissa B. Cummings · Chief Operating Officer
Chief Operating Officer
$363.0K soldCheryl Scott · Director
Director
$196.3K soldGeoffrey Clapp · Chief Product Officer
Chief Product Officer
$39.1K soldOpen-market trades
21 filings in the last 12 months| Insider | Role | Sold | Bought | Filings | Pre-arranged (10b5-1) | Last filed |
|---|---|---|---|---|---|---|
| Peter Anevski | CHIEF EXECUTIVE OFFICER | — | $1.9M | 1 | — | |
| Mark S. Livingston | CHIEF FINANCIAL OFFICER | $842.9K | — | 6 | 100% of sales | |
| Kevin K. Gordon | Director | $449.3K | — | 2 | — | |
| Allison Swartz | EVP, GC | $414.9K | — | 7 | 100% of sales | |
| Melissa B. Cummings | Chief Operating Officer | $363.0K | — | 3 | 100% of sales | |
| Cheryl Scott | Director | $196.3K | — | 1 | — | |
| Geoffrey Clapp | Chief Product Officer | $39.1K | — | 1 | — |
| Filed | Insider | Type | Shares | Avg price | Value | Held after | Source |
|---|---|---|---|---|---|---|---|
traded | Melissa B. Cummings Chief Operating Officer | SalePre-arranged (10b5-1) | 1,879 | $28.00 | $52.6K | 66,496 | |
traded | Allison Swartz EVP, GC | SalePre-arranged (10b5-1) | 3,903 | $26.10 | $101.9K | 75,816 | |
traded | Kevin K. Gordon Director | Sale | 11,500 | $27.12 | $311.9K | 6,792 | |
traded | Melissa B. Cummings Chief Operating Officer | SalePre-arranged (10b5-1) | 2,244 | $31.60 | $70.9K | 69,934 | |
traded | Allison Swartz EVP, GC | SalePre-arranged (10b5-1) | 1,798 | $25.04 | $45.0K | 82,378 | |
traded | Mark S. Livingston CHIEF FINANCIAL OFFICER | SalePre-arranged (10b5-1) | 2,517 | $25.50 | $64.2K | 75,287 | |
traded | Geoffrey Clapp Chief Product Officer | Sale | 1,530 | $25.58 | $39.1K | 59,117 | |
traded | Cheryl Scott Director | Sale | 7,439 | $26.39 | $196.3K | 19,772 | |
traded | Mark S. Livingston CHIEF FINANCIAL OFFICER | SalePre-arranged (10b5-1) | 279 | $26.20 | $7.3K | 78,626 | |
traded | Allison Swartz EVP, GC | SalePre-arranged (10b5-1) | 2,398 | $25.46 | $61.1K | 85,191 | |
traded | Kevin K. Gordon Director | Sale | 5,500 | $24.99 | $137.4K | 9,318 | |
traded | Melissa B. Cummings Chief Operating Officer | SalePre-arranged (10b5-1) | 9,578 | $25.00 | $239.5K | 73,371 | |
traded | Mark S. Livingston CHIEF FINANCIAL OFFICER | SalePre-arranged (10b5-1) | 8,275 | $25.50 | $211.0K | 79,063 | |
traded | Allison Swartz EVP, GC | SalePre-arranged (10b5-1) | 599 | $17.54 | $10.5K | 88,941 | |
traded | Allison Swartz EVP, GC | SalePre-arranged (10b5-1) | 6,856 | $17.36 | $119.0K | 89,879 | |
traded | Mark S. Livingston CHIEF FINANCIAL OFFICER | SalePre-arranged (10b5-1) | 459 | $25.50 | $11.7K | 46,983 | |
traded | Allison Swartz EVP, GC | SalePre-arranged (10b5-1) | 530 | $24.59 | $13.0K | 72,719 | |
traded | Mark S. Livingston CHIEF FINANCIAL OFFICER | SalePre-arranged (10b5-1) | 213 | $25.50 | $5.4K | 47,921 | |
traded | Allison Swartz EVP, GC | SalePre-arranged (10b5-1) | 2,398 | $26.87 | $64.4K | 73,657 | |
traded | Mark S. Livingston CHIEF FINANCIAL OFFICER | SalePre-arranged (10b5-1) | 21,303 | $25.50 | $543.2K | 48,358 | |
traded | Peter Anevski CHIEF EXECUTIVE OFFICER | Purchase | 79,500 | $24.29 | $1.9M | 680,251 |
GET /stocks/filings/vX/form-4?tickers=PGNY&filing_date.gte=2025-10-26&sort=filing_date.desc&limit=500{
"status": "OK",
"results": [
{
"tickers": [
"PGNY"
],
"issuer_cik": "0001551306",
"owner_cik": "0002066495",
"accession_number": "0001551306-26-000160",
"form_type": "4",
"filing_date": "2026-10-16",
"period_of_report": "2026-10-14",
"issuer_name": "Progyny, Inc.",
"issuer_trading_symbol": "PGNY",
"owner_name": "Cummings Melissa B",
"is_director": false,
"is_officer": true,
"is_ten_percent_owner": false,
"is_other": false,
"officer_title": "Chief Operating Officer",
"security_type": "non_derivative",
"record_type": "transaction",
"security_title": "Common Stock",
"transaction_timeliness": "O",
"aff_10b5_one": true,
"transaction_date": "2026-10-14",
"transaction_code": "S",
"equity_swap_involved": false,
"transaction_shares": 1879,
"transaction_price_per_share": 28,
"transaction_acquired_disposed": "D",
"shares_owned_following_transaction": 66496,
"transaction_value": 52612,
"not_subject_to_section_16": false,
"direct_or_indirect": "D",
"footnotes": [
{
"id": "F2",
"description": "Shares sold pursuant to a Rule 10b5-1 trading plan entered into on December 19, 2025."
}
]
},
{
"tickers": [
"PGNY"
],
"issuer_cik": "0001551306",
"owner_cik": "0001956339",
"accession_number": "0001551306-26-000158",
"form_type": "4",
"filing_date": "2026-09-28",
"period_of_report": "2026-09-23",
"issuer_name": "Progyny, Inc.",
"issuer_trading_symbol": "PGNY",
"owner_name": "Swartz Allison",
"is_director": false,
"is_officer": true,
"is_ten_percent_owner": false,
"is_other": false,
"officer_title": "EVP, GC",
"security_type": "non_derivative",
"record_type": "transaction",
"security_title": "Common Stock",
"transaction_timeliness": "O",
"aff_10b5_one": true,
"transaction_date": "2026-09-23",
"transaction_code": "S",
"equity_swap_involved": false,
"transaction_shares": 3903,
"transaction_price_per_share": 26.1,
"transaction_acquired_disposed": "D",
"shares_owned_following_transaction": 75816,
"transaction_value": 101868.3,
"not_subject_to_section_16": false,
"direct_or_indirect": "D",
"footnotes": [
{
"id": "F1",
"description": "Shares sold pursuant to a Rule 10b5-1 trading plan entered into on May 13, 2025."
}
]
}
]
}
// trimmed to 2 resultsThe response includes every Form 4 record; this page keeps open-market purchases and sales on common stock and removes duplicate joint-filer rows.
Other insider activity (not market trades) · 63 records
- Option exercises4 records
- Tax withholding41 records
- Grants and awards15 records
- Gifts1 record
- Other2 records
Reported on Form 4 but not purchases or sales in the market, so not counted in the totals above.
How to read this page
- Open-market purchase or sale
- A buy or sell of the company's stock at market price. Grants, option exercises, shares withheld for tax, gifts and employee stock plan purchases are listed separately and not counted.
- Pre-arranged (10b5-1)
- The insider marked the filing as made under a trading plan set up in advance (SEC Rule 10b5-1). The mark covers the whole filing, and an unmarked filing may still be under a plan.
- Filing date
- Insiders have two business days to report a trade. Totals and the chart use the filing date, when the trade became public.
- Counted once
- When several owners (a fund and its partners, say) report the same trade, it's counted once. Corrected filings replace the originals.
Frequently asked questions
Has Progyny, Inc.'s CEO sold stock?
No. Peter Anevski (CEO) made no open-market sales filed as CEO in the last 12 months.
How current is PGNY’s insider data?
These are PGNY Form 4 filings from the last year, refreshed daily. The Massive Form 4 API has the full, continuously updated record.
What counts as an open-market buy or sell?
Only purchases and sales at the market price. Option exercises, grants, gifts, and shares withheld for taxes are reported on Form 4 but are left out of the buy and sell totals.
Build with AI
Track PGNY insider trades with your agent
This page joins two Massive endpoints: Form 4 filings and daily prices. Ask an agent to watch for new filings:
Using the Massive API (massive.com/docs/llms.txt), check Form 4 filings for PGNY every day with transaction_code=P and tell me when an insider files an open-market purchase, with their role, shares, price and the filing link.
Nothing on this page is investment advice. All data and content is provided for informational purposes under our Terms of Service.